PFS-level studies are ongoing, with METS Engineering undertaking additional metallurgical test work to build on the high gold recoveries achieved at RPM to date (ASX Announcement: 5 August 2025), ...
This article is authored by Shaveta Sharma-Kukreja, CEO & MD, Central Square Foundation and Ajay Khanna, co-founder, Public Affairs Forum of India (PAFI).
Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...
PFS-level studies are ongoing, with METS Engineering undertaking additional metallurgical test work to build on the high gold recoveries achieved at RPM to date (ASX Announcement: 5 August 2025), ...
Quarter Marked by Execution of DoW-Funded Antimony Initiatives to Secure U.S. Domestic Antimony Supply Chain Melbourne, ...
Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...
Technical Studies Underway on Lost Soldier ProjectNorth Hadsell Drilling Returns Significant Intercepts CASPER, WY / ACCESS ...
VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / Metallic Minerals Corp. ("Metallic" or the "Company") is pleased to announce an updated NI 43-101 Mineral Resource Estimate (the " ...
Strong gold price to have material impact on economics: Since the Updated Scoping Study was released in May 2025 using a gold ...
VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / Metallic Minerals Corp. (TSX.V:MMG)(OTCQB:MMNGF)(FSE:9MM1)("Metallic" or the "Company") is pleased to announce an updated NI 43-101 Mineral Resourc ...
K2 Gold Announces Upsize Of Non-Brokered Private Placement To Up To CDN$25 Million. K2 Gold Announces Upsize of Non-Brokered Private Placement to up to CDN$25 Million9, 2026 6:27 PM EST | Source: K2 ...
K2 Gold Corporation (TSXV: KTO) (OTCQB: KTGDF) (FSE: 23K) (“K2” or the “Company”) today announced a non-brokered private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results